Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ros A. Eeles"'
Autor:
Netty Kinsella, Jana Kathlyn McHugh, Eva McGrowder, Denzil James, Ed Saunders, Elizabeth Bancroft, Zsofia Kote-Jarai, Ros A. Eeles
Publikováno v:
Journal of Clinical Oncology. 41:306-306
306 Background: Heritable risk factors account for a significant proportion of prostate cancer (PrCa) risk, of which only a minority are high risk Mendelian traits. Men of Black African and African Caribbean ancestry are at higher risk of developing
Autor:
Ros A. Eeles, Michael Sandberg, Gabriella C. Pichert, Lucy Side, Tessa Homfray, Ann-Britt Jones, Sophie Hicks, Elizabeth Bancroft
Publikováno v:
Journal of Clinical Oncology. 40:10510-10510
10510 Background: Whole genome sequencing (WGS) is now possible due to improvements in next generation sequencing technology. This gives the opportunity to incorporate genetic data into family practice health screening. The fulfilment of the potentia
Autor:
Jana Kathlyn McHugh, Holly ni Raghallaigh, Elizabeth Bancroft, Zsofia Kote-Jarai, Sarah Benafif, Ros A. Eeles
Publikováno v:
Journal of Clinical Oncology. 40:231-231
231 Background: A significant proportion of Prostate cancer (PrCa) risk is attributable to heritable risk factors of which only a minority are high risk Mendelian traits. A greater proportion of PrCa is due to the combined effect of multiple low risk
Autor:
Lisa J. Walker, Ros A. Eeles
Publikováno v:
Treatment of Cancer ISBN: 9780429169977
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70f3c01fd5a1d822635077a9f38e4efb
https://doi.org/10.1201/b17751-34
https://doi.org/10.1201/b17751-34
Autor:
Christos Mikropoulos, Christina Selkirk, Sibel Saya, Elizabeth Bancroft, Tokhir Dadaev, Charles Brendler, Edward Saunders, Daniel Leongamornlert, Elizabeth Page, Clara Cieza Borrella, The IMPACT study Collaborators And Steering Group, Sue Moss, Zsofia Kote-Jarai, Brian Helfand, Ros A. Eeles
Publikováno v:
Journal of Clinical Oncology. 33:16-16
16 Background: We retrospectively assessed the clinical application of Prostate Specific Antigen Velocity (PSA V) in the IMPACT study (Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted screening in men at higher genetic